The stock of BioCardia Inc (BCDA) has seen a -14.82% decrease in the past week, with a -23.53% drop in the past month, and a -39.31% decrease in the past quarter. The volatility ratio for the week is 8.99%, and the volatility levels for the past 30 days are at 7.30% for BCDA. The simple moving average for the past 20 days is -16.58% for BCDA’s stock, with a -52.22% simple moving average for the past 200 days.
Is It Worth Investing in BioCardia Inc (NASDAQ: BCDA) Right Now?
BCDA has 36-month beta value of 1.26. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for BCDA is 2.72M, and currently, short sellers hold a 3.17% ratio of that float. The average trading volume of BCDA on November 15, 2024 was 832.34K shares.
BCDA) stock’s latest price update
The stock price of BioCardia Inc (NASDAQ: BCDA) has dropped by -14.26 compared to previous close of 2.35. Despite this, the company has seen a fall of -14.82% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-13 that BioCardia, Inc. (NASDAQ:BCDA ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Miranda Peto – Investor Relations Peter Altman – President and CEO David McClung – Chief Financial Officer Conference Call Participants Joe Pantginis – H.C. Wainwright Kumar Raja – Brookline Capital Markets Operator Good afternoon, ladies and gentlemen.
BCDA Trading at -22.22% from the 50-Day Moving Average
After a stumble in the market that brought BCDA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.33% of loss for the given period.
Volatility was left at 7.30%, however, over the last 30 days, the volatility rate increased by 8.99%, as shares sank -23.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -19.40% lower at present.
During the last 5 trading sessions, BCDA fell by -14.82%, which changed the moving average for the period of 200-days by -70.36% in comparison to the 20-day moving average, which settled at $2.42. In addition, BioCardia Inc saw -79.78% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BCDA starting from Altman Peter, who purchase 300 shares at the price of $3.05 back on Jul 01 ’24. After this action, Altman Peter now owns 39,745 shares of BioCardia Inc, valued at $915 using the latest closing price.
Altman Peter, the President and CEO of BioCardia Inc, purchase 200 shares at $2.99 during a trade that took place back on Jun 28 ’24, which means that Altman Peter is holding 39,445 shares at $598 based on the most recent closing price.
Stock Fundamentals for BCDA
Current profitability levels for the company are sitting at:
- -84.62 for the present operating margin
- -3.46 for the gross margin
The net margin for BioCardia Inc stands at -108.76. The total capital return value is set at -1.75. Equity return is now at value -737.89, with -154.22 for asset returns.
Based on BioCardia Inc (BCDA), the company’s capital structure generated 0.28 points at debt to capital in total, while cash flow to debt ratio is standing at -6.99. The debt to equity ratio resting at 0.38. The interest coverage ratio of the stock is -667.56.
Currently, EBITDA for the company is -11.56 million with net debt to EBITDA at 0.66. When we switch over and look at the enterprise to sales, we see a ratio of 44.67. The receivables turnover for the company is 7.1for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.78.
Conclusion
To put it simply, BioCardia Inc (BCDA) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
